| Year |
Citation |
Score |
| 2020 |
Si L, Willis MS, Asseburg C, Nilsson A, Tew M, Clarke PM, Lamotte M, Ramos M, Shao H, Shi L, Zhang P, McEwan P, Ye W, Herman WH, Kuo S, et al. Evaluating the Ability of Economic Models of Diabetes to Simulate New Cardiovascular Outcomes Trials: A Report on the Ninth Mount Hood Diabetes Challenge. Value in Health : the Journal of the International Society For Pharmacoeconomics and Outcomes Research. 23: 1163-1170. PMID 32940234 DOI: 10.1016/J.Jval.2020.04.1832 |
0.332 |
|
| 2020 |
Fan Y, Shen Y, Zhou J, Shi L, Nauman E, Katzmarzyk PT, Price-Haywood EG, Horswell R, Chu S, Bazzano AN, Hu G. Visit-to-Visit Hemoglobin A Variability Is Associated With the Risk of Lower-Extremity Amputation in Patients With Type 2 Diabetes. Diabetes Care. PMID 32887709 DOI: 10.2337/Dc20-1615 |
0.357 |
|
| 2020 |
Shao H, Fonseca V, Furman R, Meneghini L, Shi L. Impact of Quality Improvement (QI) Program on 5-Year Risk of Diabetes-Related Complications: A Simulation Study. Diabetes Care. PMID 32887705 DOI: 10.2337/Dc20-0465 |
0.357 |
|
| 2020 |
Wharton MK, Shi L, Eragoda S, Monnette AM, Nauman E, Price-Haywood EG, Hu G, Bazzano AN. Qualitative Analysis of Health Systems Utilizing Non-Face-to-Face Chronic Care Management for Medicare-Insured Patients With Diabetes. The Journal of Ambulatory Care Management. 43: 326-334. PMID 32858736 DOI: 10.1097/Jac.0000000000000342 |
0.301 |
|
| 2020 |
Monnette A, Stoecker C, Nauman E, Shi L. The impact of Medicaid expansion on access to care and preventive care for adults with diabetes and depression. Journal of Diabetes and Its Complications. 107663. PMID 32660796 DOI: 10.1016/J.Jdiacomp.2020.107663 |
0.33 |
|
| 2020 |
Gu S, Wang X, Shi L, Sun Q, Hu X, Gu Y, Sun X, Dong H. Health-related quality of life of type 2 diabetes patients hospitalized for a diabetes-related complication. Quality of Life Research : An International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation. PMID 32410144 DOI: 10.1007/S11136-020-02524-3 |
0.343 |
|
| 2020 |
Shao H, Shi L, Fonseca VA. Using the BRAVO Risk Engine to Predict Cardiovascular Outcomes in Clinical Trials With Sodium-Glucose Transporter 2 Inhibitors. Diabetes Care. PMID 32345650 DOI: 10.2337/Dc20-0227 |
0.324 |
|
| 2020 |
Yoshida Y, Cheng X, Shao H, Fonseca VA, Shi L. A Systematic Review of Cost-Effectiveness of Sodium-Glucose Cotransporter Inhibitors for Type 2 Diabetes. Current Diabetes Reports. 20: 12. PMID 32166504 DOI: 10.1007/S11892-020-1292-5 |
0.341 |
|
| 2020 |
Zhang Y, Wu J, Chen Y, Shi L. EQ-5D-3L Decrements by Diabetes Complications and Comorbidities in China. Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders. PMID 32152932 DOI: 10.1007/S13300-020-00788-Z |
0.36 |
|
| 2020 |
Peng XV, Ayyagari R, Lubwama R, Shi L, Price-Haywood EG, Hollander P, Fonseca V. Impact of Simultaneous Versus Sequential Initiation of Basal Insulin and Glucagon-like Peptide-1 Receptor Agonists on HbA1c in Type 2 Diabetes: A Retrospective Observational Study. Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders. PMID 32112204 DOI: 10.1007/S13300-020-00783-4 |
0.314 |
|
| 2020 |
Shen Y, Shi L, Nauman E, Katzmarzyk P, Price-Haywood E, Bazzano A, Nigam S, Hu G. Association between Hemoglobin A1c and Stroke Risk in Patients with Type 2 Diabetes. Journal of Stroke. 22: 87-98. PMID 32027794 DOI: 10.5853/Jos.2019.01704 |
0.316 |
|
| 2020 |
Hong D, Shen Y, Monnette A, Liu S, Shao H, Nauman E, Price-Haywood E, Hu G, Shi L. Does the Encounter Type Matter When Defining Diabetes Complications in Electronic Health Records? Medical Care. PMID 32011424 DOI: 10.1097/Mlr.0000000000001297 |
0.335 |
|
| 2020 |
Shao H, Shi L, Fonseca V. Comment on Segar et al. Machine Learning to Predict the Risk of Incident Heart Failure Hospitalization Among Patients With Diabetes: The WATCH-DM Risk Score. Diabetes Care 2019;42:2298-2306. Diabetes Care. 43: e25. PMID 31959647 DOI: 10.2337/Dc19-1891 |
0.319 |
|
| 2020 |
Yoshida Y, Shi L, Hong D, Nauman E, Hu G, Katzmarzyk PT, Price-Haywood EG, Bazzano AN, Shen Y, Fonseca V. 42-LB: Factors Associated with Use of Diabetes Self-Management Education and Support Programs in Newly Diagnosed Type 2 Diabetes Patients in Louisiana Diabetes. 69. DOI: 10.2337/Db20-42-Lb |
0.35 |
|
| 2020 |
Shao H, Yang S, Fonseca V, Bian J, Shi L. 3-OR: Intensive Glycemic Control Can Reduce Major Adverse Cardiovascular Events (MACE): A Bayesian’s Narrative Diabetes. 69. DOI: 10.2337/Db20-3-Or |
0.301 |
|
| 2020 |
Kianmehr H, Yang S, Fonseca V, Shi L, Brown JD, Guo Y, Shao H. 1401-P: Life Expectancy of Individuals with Type 2 Diabetes Mellitus (T2DM) in the United States Diabetes. 69. DOI: 10.2337/Db20-1401-P |
0.315 |
|
| 2020 |
Hong D, Shen Y, Monnette A, Liu S, Shao H, Nauman E, Price-Haywood E, Hu G, Shi L. Pdb5 Does The Encounter Type Matter When Defining Diabetes Complications In Electronic Health Records Value in Health. 23. DOI: 10.1016/J.Jval.2020.04.195 |
0.328 |
|
| 2019 |
Geer EB, Sisco J, Adelman DT, Ludlam WH, Haviv A, Gelbaum D, Liu S, Mathias SD, Shi L. Observed discordance between outcomes reported by acromegaly patients and their treating endocrinology medical provider. Pituitary. PMID 31808101 DOI: 10.1007/S11102-019-01013-2 |
0.308 |
|
| 2019 |
Shao H, Yang S, Stoecker C, Fonseca V, Hong D, Shi L. Addressing Regional Differences in Diabetes Progression: Global Calibration for Diabetes Simulation Model. Value in Health : the Journal of the International Society For Pharmacoeconomics and Outcomes Research. 22: 1402-1409. PMID 31806197 DOI: 10.1016/J.Jval.2019.08.007 |
0.327 |
|
| 2019 |
Shen Y, Shi L, Nauman E, Katzmarzyk PT, Price-Haywood EG, Bazzano AN, Nigam S, Hu G. Association between body mass index and stroke risk among patients with type 2 diabetes. The Journal of Clinical Endocrinology and Metabolism. PMID 31529060 DOI: 10.1210/Clinem/Dgz032 |
0.306 |
|
| 2019 |
Shao Y, Shao H, Sawhney MS, Shi L. Serum uric acid as a risk factor of all-cause mortality and cardiovascular events among type 2 diabetes population: Meta-analysis of correlational evidence. Journal of Diabetes and Its Complications. 107409. PMID 31439471 DOI: 10.1016/J.Jdiacomp.2019.07.006 |
0.306 |
|
| 2019 |
Shi Q, Liu S, Fonseca VA, Thethi TK, Shi L. Effect of metformin on neurodegenerative disease among elderly adult US veterans with type 2 diabetes mellitus. Bmj Open. 9: e024954. PMID 31366635 DOI: 10.1136/Bmjopen-2018-024954 |
0.339 |
|
| 2019 |
Bazzano AN, Monnette AM, Wharton MK, Price-Haywood EG, Nauman E, Dominick P, Glover C, Hu G, Shi L. Older patients' preferences and views related to non-face-to-face diabetes chronic care management: a qualitative study from southeast Louisiana. Patient Preference and Adherence. 13: 901-911. PMID 31213782 DOI: 10.2147/Ppa.S201072 |
0.328 |
|
| 2019 |
Shao H, Fonseca V, Stoecker C, Liu S, Shi L. Correction to: Novel Risk Engine for Diabetes Progression and Mortality in USA: Building, Relating, Assessing, and Validating Outcomes (BRAVO). Pharmacoeconomics. PMID 31098945 DOI: 10.1007/S40273-019-00807-3 |
0.31 |
|
| 2019 |
Monnette AM, Wharton MK, Zhao Y, Fonseca VA, Shi L. Post-ACA Racial Disparity of Eye Examinations Among the U.S. Noninstitutionalized Population With Diabetes: 2014-2015. Diabetes Care. PMID 30862653 DOI: 10.2337/Dc18-1991 |
0.352 |
|
| 2019 |
Shao H, Yang S, Fonseca V, Stoecker C, Shi L. Estimating Quality of Life Decrements Due to Diabetes Complications in the United States: The Health Utility Index (HUI) Diabetes Complication Equation. Pharmacoeconomics. PMID 30778865 DOI: 10.1007/S40273-019-00775-8 |
0.364 |
|
| 2019 |
Cai X, Shi L, Yang W, Gu S, Chen Y, Nie L, Ji L. Cost-effectiveness analysis of dapagliflozin treatment versus metformin treatment in Chinese population with type 2 diabetes. Journal of Medical Economics. 1. PMID 30663458 DOI: 10.1080/13696998.2019.1570220 |
0.362 |
|
| 2019 |
Ye JH, Qian MH, Shi LZ, Ye L. Association Between Metformin and Sulfonylurea Monotherapies and Cancer Incidence: A Real-World Cohort Study in Shanghai, China. Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders. 10: 245-258. PMID 30623338 DOI: 10.1007/S13300-018-0557-3 |
0.337 |
|
| 2019 |
Khatib J, Shao Y, Shi L, Fonseca V. 240-OR: Impact of Insulin Treatment on Primary Outcomes in Cardiovascular Outcome Trials Diabetes. 68. DOI: 10.2337/Db19-240-Or |
0.337 |
|
| 2019 |
Shen Y, Shi L, Nauman E, Katzmarzyk P, Price-Haywood EG, Bazzano AN, Nigam S, Hu G. 239-OR: Association between Hemoglobin A1c and Stroke Risk in Patients with Type 2 Diabetes Diabetes. 68. DOI: 10.2337/Db19-239-Or |
0.346 |
|
| 2019 |
SHAO H, SHI L, FURMAN RE, MENEGHINI L, HARLAN TS, FONSECA V. 174-LB: Impact of Quality Improvement (QI) Program on 5-Year Risk of Diabetes-Related Complications Diabetes. 68: 174-LB. DOI: 10.2337/Db19-174-Lb |
0.342 |
|
| 2019 |
GU S, SHEN Y, SHI L, DONG H. 1295-P: Economic Evaluation of Drug Combination Strategy for Type 2 Diabetes in China Diabetes. 68: 1295-P. DOI: 10.2337/Db19-1295-P |
0.304 |
|
| 2019 |
Shao H, Yang S, Stoecker C, Fonseca V, Cheng X, Shi L. 1248-P: Estimating Diabetes Duration from Electronic Medical Records (EMRs) with an Intrinsic Diabetes Risk Prediction Model: From Clinical Trial to Real-World Clinical Practice Diabetes. 68. DOI: 10.2337/Db19-1248-P |
0.36 |
|
| 2019 |
Gu S, Yu H, Li Y, Shen Y, Zhen X, Gu Y, Wei J, Shi L, Dong H. PP93 Efficacy Of Pharmacological Treatments For Type 2 Diabetes In China International Journal of Technology Assessment in Health Care. 35: 55-56. DOI: 10.1017/S0266462319002319 |
0.332 |
|
| 2019 |
Yu H, Gu S, Zhen X, Li Y, Shi L, Dong H. Pdg8 Efficacy Of Pharmacological Monotherapies For Type 2 Diabetes In China Value in Health. 22. DOI: 10.1016/J.Jval.2019.04.687 |
0.331 |
|
| 2019 |
Hong D, Fort D, Price-Haywood E, Shi L. Pdb130 Risk Equations For Complications Of Type2 Diabetes Using Real-World Electronic Medical Records: Localized Vs. Generalizable Value in Health. 22. DOI: 10.1016/J.Jval.2019.04.677 |
0.317 |
|
| 2018 |
Bazzano AN, Wharton MK, Monnette A, Nauman E, Price-Haywood E, Glover C, Dominick P, Malone P, Hu G, Shi L. Barriers and Facilitators in Implementing Non-Face-to-Face Chronic Care Management in an Elderly Population with Diabetes: A Qualitative Study of Physician and Health System Perspectives. Journal of Clinical Medicine. 7. PMID 30463310 DOI: 10.3390/Jcm7110451 |
0.317 |
|
| 2018 |
Shen Y, Shi L, Nauman E, Katzmarzyk PT, Price-Haywood EG, Yin P, Bazzano AN, Nigam S, Hu G. Race and sex differences in rates of diabetic complications. Journal of Diabetes. PMID 30315628 DOI: 10.1111/1753-0407.12869 |
0.333 |
|
| 2018 |
Shao H, Fonseca V, Stoecker C, Liu S, Shi L. Novel Risk Engine for Diabetes Progression and Mortality in USA: Building, Relating, Assessing, and Validating Outcomes (BRAVO). Pharmacoeconomics. PMID 29725871 DOI: 10.1007/S40273-018-0662-1 |
0.348 |
|
| 2018 |
Yeager VA, Wharton MK, Monnette A, Price-Haywood EG, Nauman E, Angove RSM, Shi L. Non-Face-to-Face Chronic Care Management: A Qualitative Study Assessing the Implementation of a New CMS Reimbursement Strategy. Population Health Management. PMID 29658847 DOI: 10.1089/Pop.2017.0196 |
0.342 |
|
| 2018 |
Yi Y, Li Y, Hou A, Ge Y, Xu Y, Xiong G, Yang X, Acevedo SA, Shi L, Xu H. A Retrospective Cohort Study of Patients with Type 2 Diabetes in China: Associations of Hypoglycemia with Health Care Resource Utilization and Associated Costs. Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders. PMID 29623592 DOI: 10.1007/S13300-018-0409-1 |
0.374 |
|
| 2018 |
Shi Q, Liu S, Krousel-Wood M, Shao H, Fonseca V, Shi L. Long-term Outcomes Associated with Triple-Goal Achievement in Patients with Type 2 Diabetes Mellitus (T2DM). Diabetes Research and Clinical Practice. PMID 29596940 DOI: 10.1016/J.Diabres.2018.02.013 |
0.338 |
|
| 2018 |
Duru OK, Mangione CM, Rodriguez HP, Ross-Degnan D, Wharam JF, Black B, Kho A, Huguet N, Angier H, Mayer V, Siscovick D, Kraschnewski JL, Shi L, Nauman E, Gregg EW, et al. Introductory Overview of the Natural Experiments for Translation in Diabetes 2.0 (NEXT-D2) Network: Examining the Impact of US Health Policies and Practices to Prevent Diabetes and Its Complications. Current Diabetes Reports. 18: 8. PMID 29399715 DOI: 10.1007/S11892-018-0977-5 |
0.339 |
|
| 2018 |
SHAO H, YANG S, FONSECA V, JI X, SHI L. Projecting Long-Term Diabetes Complications through a BRAVO-Based Mock Simulation for Promoting Diabetes Prevention Program (DPP) Diabetes. 67: 701-P. DOI: 10.2337/Db18-701-P |
0.368 |
|
| 2018 |
YIN P, SHI L, NAUMAN E, KATZMARZYK PT, PRICE-HAYWOOD EG, BAZZANO AN, SHEN Y, HU G. Race and Sex Differences in Diabetic Complications in a Large Health Care System Diabetes. 67: 1576-P. DOI: 10.2337/Db18-1576-P |
0.332 |
|
| 2018 |
Shao H, Yang S, Fonseca V, Stoecker C, Shi L. Complications Related Health Utility Decrements for Type 2 Diabetes Population in the United States Value in Health. 21: S77. DOI: 10.1016/J.Jval.2018.04.539 |
0.328 |
|
| 2018 |
He X, Shi L, Wu J. Use of Anti-Diabetic Medication is Not Associated with Cancer Risk in Chinese Patients with Type 2 Diabetes Value in Health. 21. DOI: 10.1016/J.Jval.2018.04.119 |
0.37 |
|
| 2017 |
He X, Shi L, Wu J. Retrospective database analysis of cancer risk in patients with type 2 diabetes mellitus in China. Current Medical Research and Opinion. 1-22. PMID 29278016 DOI: 10.1080/03007995.2017.1421527 |
0.329 |
|
| 2016 |
Shao H, Zhai S, Zou D, Mir MU, Zawadzki NK, Shi Q, Liu S, Shi L. Cost-Effectiveness Analysis of Dapagliflozin versus Glimepiride as Monotherapy in Chinese Population with Type 2 Diabetes Mellitus. Current Medical Research and Opinion. 1-32. PMID 27817216 DOI: 10.1080/03007995.2016.1257978 |
0.362 |
|
| 2016 |
Shi Q, Fonseca V, Krousel-Wood M, Zhao Y, Nellans FP, Luo Q, Shi L. Will the Affordable Care Act (ACA) Improve Racial/Ethnic Disparity of Eye Examination Among US Working-Age Population with Diabetes? Current Diabetes Reports. 16: 58. PMID 27155608 DOI: 10.1007/S11892-016-0749-Z |
0.303 |
|
| 2015 |
Zhao Y, Kachroo S, Kawabata H, Colilla S, Mukherjee J, Fonseca V, Iloeje U, Shi L. ASSOCIATION BETWEEN HYPOGLYCEMIA AND FALL-RELATED FRACTURES AND HEALTH CARE UTILIZATION IN OLDER VETERANS WITH TYPE 2 DIABETES. Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists. PMID 26492544 DOI: 10.4158/Ep15640.Or |
0.36 |
|
| 2015 |
Shi Q, Nellans FP, Shi L. Affordable Care Act and Diabetes Mellitus. Current Diabetes Reports. 15: 106. PMID 26458377 DOI: 10.1007/S11892-015-0679-1 |
0.361 |
|
| 2015 |
Shi L, Ye X, Lu M, Wu EQ, Sharma H, Thomason D, Zhang M, Wang Y, Fonseca VA. Glycemic and Cholesterol Control Versus Single-Goal Control in US Veterans with Newly Diagnosed Type 2 Diabetes: A Retrospective Observational Study. Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders. PMID 26202185 DOI: 10.1007/S13300-015-0122-2 |
0.328 |
|
| 2015 |
Deng J, Gu S, Shao H, Dong H, Zou D, Shi L. Cost-effectiveness analysis of exenatide twice daily (BID) vs insulin glargine once daily (QD) as add-on therapy in Chinese patients with Type 2 diabetes mellitus inadequately controlled by oral therapies. Journal of Medical Economics. 1-16. PMID 26134916 DOI: 10.3111/13696998.2015.1067622 |
0.353 |
|
| 2015 |
Gu S, Shi J, Tang Z, Sawhney M, Hu H, Shi L, Fonseca V, Dong H. Comparison of glucose lowering effect of metformin and acarbose in type 2 diabetes mellitus: a meta-analysis. Plos One. 10: e0126704. PMID 25961824 DOI: 10.1371/Journal.Pone.0126704 |
0.335 |
|
| 2015 |
Gu S, Deng J, Shi L, Mu Y, Dong H. Cost-effectiveness of saxagliptin versus glimepiride as a second-line therapy added to metformin in Type 2 diabetes in China. Journal of Medical Economics. 1-40. PMID 25950193 DOI: 10.3111/13696998.2015.1049542 |
0.363 |
|
| 2015 |
Katalenich B, Shi L, Liu S, Shao H, McDuffie R, Carpio G, Thethi T, Fonseca V. Evaluation of a Remote Monitoring System for Diabetes Control. Clinical Therapeutics. 37: 1216-25. PMID 25869625 DOI: 10.1016/J.Clinthera.2015.03.022 |
0.345 |
|
| 2015 |
Wang L, Sawhney M, Zhao Y, Carpio GR, Fonseca V, Shi L. Association Between Colchicine and Risk of Diabetes Among the Veterans Affairs Population With Gout. Clinical Therapeutics. 37: 1206-15. PMID 25857595 DOI: 10.1016/J.Clinthera.2015.03.010 |
0.364 |
|
| 2015 |
Kachroo S, Kawabata H, Colilla S, Shi L, Zhao Y, Mukherjee J, Iloeje U, Fonseca V. Association between hypoglycemia and fall-related events in type 2 diabetes mellitus: analysis of a U.S. commercial database. Journal of Managed Care & Specialty Pharmacy. 21: 243-53. PMID 25726033 DOI: 10.18553/Jmcp.2015.21.3.243 |
0.373 |
|
| 2015 |
Hu H, Sawhney M, Shi L, Duan S, Yu Y, Wu Z, Qiu G, Dong H. A systematic review of the direct economic burden of type 2 diabetes in china. Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders. 6: 7-16. PMID 25652613 DOI: 10.1007/S13300-015-0096-0 |
0.385 |
|
| 2014 |
Shi L, Shao H, Zhao Y, Thomas NA. Is hypoglycemia fear independently associated with health-related quality of life? Health and Quality of Life Outcomes. 12: 167. PMID 25433668 DOI: 10.1186/S12955-014-0167-3 |
0.303 |
|
| 2014 |
Shi Q, Zhao Y, Fonseca V, Krousel-Wood M, Shi L. Racial disparity of eye examinations among the U.S. working-age population with diabetes: 2002-2009. Diabetes Care. 37: 1321-8. PMID 24574354 DOI: 10.2337/Dc13-1038 |
0.327 |
|
| 2013 |
Zhao W, Shi L, Fonseca VA, He J, Shao D, Zhao J, Chen Q, Yin A. Screening patients with type 2 diabetes for active tuberculosis in communities of China. Diabetes Care. 36: e159-60. PMID 23970731 DOI: 10.2337/Dc13-1007 |
0.305 |
|
| 2013 |
Shi L, Ye X, Lu M, Wu EQ, Sharma H, Thomason D, Fonseca VA. Clinical and economic benefits associated with the achievement of both HbA1c and LDL cholesterol goals in veterans with type 2 diabetes. Diabetes Care. 36: 3297-304. PMID 23801723 DOI: 10.2337/Dc13-0149 |
0.36 |
|
| 2013 |
Shi L, Thethi TK, Zhao Y. Diabetes risk assessment models: we have the base, but not enough? Journal of Diabetes and Its Complications. 27: 305-6. PMID 23541444 DOI: 10.1016/J.Jdiacomp.2013.02.006 |
0.316 |
|
| 2012 |
Williams SA, Shi L, Brenneman SK, Johnson JC, Wegner JC, Fonseca V. The burden of hypoglycemia on healthcare utilization, costs, and quality of life among type 2 diabetes mellitus patients. Journal of Diabetes and Its Complications. 26: 399-406. PMID 22699113 DOI: 10.1016/J.Jdiacomp.2012.05.002 |
0.373 |
|
| 2012 |
Zhao Y, Campbell CR, Fonseca V, Shi L. Impact of hypoglycemia associated with antihyperglycemic medications on vascular risks in veterans with type 2 diabetes. Diabetes Care. 35: 1126-32. PMID 22432106 DOI: 10.2337/Dc11-2048 |
0.325 |
|
| 2012 |
Xie Y, Shi L, Xiong X, Wu E, Veasley C, Dade C. Economic burden and quality of life of vulvodynia in the United States. Current Medical Research and Opinion. 28: 601-8. PMID 22356119 DOI: 10.1185/03007995.2012.666963 |
0.306 |
|
| 2012 |
Liu S, Zhao Y, Hempe JM, Fonseca V, Shi L. Economic burden of hypoglycemia in patients with Type 2 diabetes. Expert Review of Pharmacoeconomics & Outcomes Research. 12: 47-51. PMID 22280196 DOI: 10.1586/Erp.11.87 |
0.368 |
|
| 2012 |
Shi L, Liu J, Zhao Y. Comparative effectiveness in pain-related outcomes and health care utilizations between veterans with major depressive disorder treated with duloxetine and other antidepressants: a retrospective propensity score-matched comparison. Pain Practice : the Official Journal of World Institute of Pain. 12: 374-81. PMID 21951787 DOI: 10.1111/J.1533-2500.2011.00495.X |
0.311 |
|
| 2012 |
Zhao Y, Liu J, Zhao Y, Thethi T, Fonseca V, Shi L. Predictors of duloxetine versus other treatments among veterans with diabetic peripheral neuropathic pain: a retrospective study. Pain Practice : the Official Journal of World Institute of Pain. 12: 366-73. PMID 21951753 DOI: 10.1111/J.1533-2500.2011.00494.X |
0.337 |
|
| 2012 |
Zhao Y, Shi L, Edgren B. PDB99 Underused Diabetes Monitoring Services and Out-of-Pocket Health Care Expenses Share Among Americans With Diabetes Mellitus Value in Health. 15: A189. DOI: 10.1016/J.Jval.2012.03.1020 |
0.344 |
|
| 2011 |
Pawaskar M, Zagar A, Sugihara T, Shi L. Healthcare resource utilization and costs assessment of type 2 diabetes patients initiating exenatide BID or glargine: a retrospective database analysis. Journal of Medical Economics. 14: 16-27. PMID 21158486 DOI: 10.3111/13696998.2010.544797 |
0.382 |
|
| 2011 |
Shi L, Zhao Y, Szymanski K, Yau L, Fonseca V. Impact of thiazolidinedione safety warnings on medication use patterns and glycemic control among veterans with diabetes mellitus. Journal of Diabetes and Its Complications. 25: 143-50. PMID 20708416 DOI: 10.1016/J.Jdiacomp.2010.06.003 |
0.365 |
|
| 2011 |
Zhao Y, Shi L, Fonseca V, Campbell C, Wu E. PDB1 Association Between Hypoglycemia and Medication Possession Ratio Among Veterans with Type 2 Diabetes Mellitus (T2DM) Value in Health. 14: A471. DOI: 10.1016/J.Jval.2011.08.1304 |
0.347 |
|
| 2011 |
Zhao Y, Fonseca V, Shi L. PDB18 FACTORS ASSOCIATED WITH ROUTINE PROPER MONITORING OF DIABETES CARE AMONG THE NON-INSTITUTIONALIZED POPULATION IN THE UNITED STATES: A RETROSPECTIVE ANALYSIS OF THE 2007 MEDICAL EXPENDITURE PANEL SURVEY (MEPS) Value in Health. 14: A94. DOI: 10.1016/J.Jval.2011.02.526 |
0.338 |
|
| 2011 |
Zhao Y, Shi L, Fonseca V, Campbell C. PDB5 THE IMPACT OF ANTIDIABETIC-INDUCED HYPOGLYCEMIA ON CLINICAL OUTCOMES AND RESOURCE UTILIZATION AMONG VETERANS WITH TYPE-2 DIABETES MELLITUS (T2DM) Value in Health. 14: A91. DOI: 10.1016/J.Jval.2011.02.513 |
0.346 |
|
| 2010 |
Thethi TK, Yau CL, Shi L, Leger S, Nagireddy P, Waddadar J, Surampudi P, John-Kalarickal J, Yenoby L, Fonseca V. Time to recovery in diabetes and comorbidities following Hurricane Katrina. Disaster Medicine and Public Health Preparedness. 4: S33-8. PMID 23105033 DOI: 10.1001/Dmp.2010.10 |
0.346 |
|
| 2010 |
Shi L, Liu J, Campbell C, Zhao Y. Factors associated with duloxetine treatment among patients with major depressive disorder in Veterans Health Administration: a retrospective study. Current Medical Research and Opinion. 26: 2715-21. PMID 20973616 DOI: 10.1185/03007995.2010.530140 |
0.319 |
|
| 2009 |
Molife C, Lee LJ, Shi L, Sawhney M, Lenox SM. Assessment of patient-reported outcomes of insulin pen devices versus conventional vial and syringe Diabetes Technology and Therapeutics. 11: 529-538. PMID 19698067 DOI: 10.1089/Dia.2009.0007 |
0.352 |
|
| 2009 |
Fonseca VA, Smith H, Kuhadiya N, Leger SM, Yau CL, Reynolds K, Shi L, McDuffie RH, Thethi T, John-Kalarickal J. Impact of a natural disaster on diabetes: exacerbation of disparities and long-term consequences. Diabetes Care. 32: 1632-8. PMID 19542210 DOI: 10.2337/Dc09-0670 |
0.337 |
|
| 2008 |
Bazzano LA, Lee LJ, Shi L, Reynolds K, Jackson JA, Fonseca V. Safety and efficacy of glargine compared with NPH insulin for the treatment of Type 2 diabetes: a meta-analysis of randomized controlled trials. Diabetic Medicine : a Journal of the British Diabetic Association. 25: 924-32. PMID 18959605 DOI: 10.1111/J.1464-5491.2008.02517.X |
0.317 |
|
| 2008 |
Ahn J, McCombs JS, Jung C, Croudace TJ, McDonnell D, Ascher-Svanum H, Edgell ET, Shi L. Classifying patients by antipsychotic adherence patterns using latent class analysis: characteristics of nonadherent groups in the California Medicaid (Medi-Cal) program. Value in Health : the Journal of the International Society For Pharmacoeconomics and Outcomes Research. 11: 48-56. PMID 18237360 DOI: 10.1111/J.1524-4733.2007.00214.X |
0.624 |
|
| 2008 |
Shi L, Ascher-Svanum H, Chiang Y, Fonseca V, Winstead D. PMH17 METABOLIC MONITORING AMONG SCHIZOPHRENIA PATIENTS INITIATED ON ATYPICAL ANTIPSYCHOTICS IN THE VETERAN HEALTH ADMINISTRATION Value in Health. 11: A114. DOI: 10.1016/S1098-3015(10)70366-1 |
0.32 |
|
| 2007 |
Shi L, Hodges M, Yurgin N, Boye KS. Impact of dose frequency on compliance and health outcomes: a literature review (1966-2006). Expert Review of Pharmacoeconomics & Outcomes Research. 7: 187-202. PMID 20528445 DOI: 10.1586/14737167.7.2.187 |
0.305 |
|
| 2007 |
McCombs JS, Ahn J, Tencer T, Shi L. The impact of unrecognized bipolar disorders among patients treated for depression with antidepressants in the fee-for-services California Medicaid (Medi-Cal) program: a 6-year retrospective analysis. Journal of Affective Disorders. 97: 171-9. PMID 16860396 DOI: 10.1016/J.Jad.2006.06.018 |
0.628 |
|
| 2005 |
Zhu B, Tunis SL, Zhao Z, Baker RW, Lage MJ, Shi L, Tohen M. Service utilization and costs of olanzapine versus divalproex treatment for acute mania: results from a randomized, 47-week clinical trial. Current Medical Research and Opinion. 21: 555-64. PMID 15899104 DOI: 10.1185/030079905X38259 |
0.306 |
|
| 2004 |
Shi L, Thiebaud P, McCombs JS. The impact of unrecognized bipolar disorders for patients treated for depression with antidepressants in the fee-for-services California Medicaid (Medi-Cal) program. Journal of Affective Disorders. 82: 373-83. PMID 15555688 DOI: 10.1016/J.Jad.2004.03.009 |
0.64 |
|
| 2004 |
Shi L, Namjoshi MA, Swindle R, Yu X, Risser R, Baker RW, Tohen M. Effects of olanzapine alone and olanzapine/fluoxetine combination on health-related quality of life in patients with bipolar depression: secondary analyses of a double-blind, placebo-controlled, randomized clinical trial. Clinical Therapeutics. 26: 125-34. PMID 14996525 DOI: 10.1016/S0149-2918(04)90013-6 |
0.303 |
|
| 2003 |
Birnbaum HG, Shi L, Dial E, Oster EF, Greenberg PE, Mallett DA. Economic consequences of not recognizing bipolar disorder patients: a cross-sectional descriptive analysis. The Journal of Clinical Psychiatry. 64: 1201-9. PMID 14658969 DOI: 10.4088/Jcp.V64N1010 |
0.354 |
|
| 2003 |
McCombs JS, Shi L, Croghan TW, Stimmel GL. Access to drug therapy and substitution between alternative antidepressants following an expansion of the California Medicaid formulary. Health Policy (Amsterdam, Netherlands). 65: 301-11. PMID 12941496 DOI: 10.1016/S0168-8510(03)00019-8 |
0.641 |
|
| 2003 |
Thiebaud P, McCombs J, Shi L. PMH28: THE IMPACT OF UNRECOGNIZED BIPOLAR DISORDERS FOR PATIENTS TREATED WITH ANTIDEPRESSANT MEDICATIONS Value in Health. 6: 352-353. DOI: 10.1016/S1098-3015(10)64230-1 |
0.311 |
|
| 2002 |
McCombs JS, Shi L, Stimmel GL, Croghan TW. A retrospective analysis of the revocation of prior authorization restrictions and the use of antidepressant medications for treating major depressive disorder. Clinical Therapeutics. 24: 1939-59; discussion . PMID 12501884 DOI: 10.1016/S0149-2918(02)80090-X |
0.619 |
|
| 2002 |
Shi L, Namjoshi MA, Zhang F, Gandhi G, Edgell ET, Tohen M, Breier A, Haro JM. Olanzapine versus haloperidol in the treatment of acute mania: clinical outcomes, health-related quality of life and work status. International Clinical Psychopharmacology. 17: 227-37. PMID 12177585 DOI: 10.1097/00004850-200209000-00003 |
0.324 |
|
| 2001 |
Shi L, Namjoshi M, Zhang F, Edgell E, Tohen M. PMH21: CLINICAL AND HEALTH-RELATED QUALITY OF LIFE OUTCOMES ASSOCIATED WITH OLANZAPINE IN PATIENTS WITH BIPOLAR DISORDER AS COMPARED WITH HALOPERIDOL Value in Health. 4: 459. DOI: 10.1016/S1098-3015(11)71630-8 |
0.313 |
|
| 2000 |
McCombs JS, Luo M, Johnstone BM, Shi L. The use of conventional antipsychotic medications for patients with schizophrenia in a medicaid population: therapeutic and cost outcomes over 2 years. Value in Health : the Journal of the International Society For Pharmacoeconomics and Outcomes Research. 3: 222-31. PMID 16464186 DOI: 10.1046/J.1524-4733.2000.33004.X |
0.638 |
|
| Show low-probability matches. |